Claude Designed Proteins That Worked in the Lab
Claude designed protein binders that hit 14 of 15 targets, landing a 26.8 percent success rate where the field usually sits at 10 to 15 percent.
Articles tagged Claude Science
Anthropic Pharma Takes On Diseases Big Pharma Skips
Anthropic launches its own drug discovery programs targeting diseases big pharma calls unprofitable. Our AI health verdict.
Claude Science: Anthropic’s New Lab AI Workbench
Claude Science is Anthropic's new research workbench with 60 skills across genomics, proteomics, and cheminformatics, integrated with NVIDIA BioNeMo.